Treatment of Intertrochanteric Fracture With New Type of Intramedullary Nail

Sponsor
Peifu Tang (Other)
Overall Status
Unknown status
CT.gov ID
NCT01437176
Collaborator
(none)
36
1
2
47
0.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether this new intramedullary fixation is effective in the treatment of intertrochanteric fracture.

Condition or Disease Intervention/Treatment Phase
  • Device: new type of intramedullary nail
  • Device: The intramedullary nail of PFNA
Phase 4

Detailed Description

With the progress of aging society, elderly patients with intertrochanteric fractures were occurred more and more. The best recommend treatment is surgical treatment of intramedullary fixation. However, existing methods of intramedullary fixation could not be restored the integrated interior support, and it will occur early hip varus. Meanwhile, the varus deformity will no longer develop if the two ends contact with wach other. This new intramedullary fixation device can overcome the existing shortage of intramedullary fixation devices and supporting the inside of the problem. It can prompting the fracture site to obtain a stronger initial stability, improve fracture healing rate, reduce the incidence of varus and allow patients with early weight-bearing walking.

This new type of intramedullary fixation of intertrochanteric fractures of devices, including a proximal femoral anatomy and adapt to proximal femoral nail, proximal femoral nail through the femoral head and distal femur compression screw locking screw, its main features are:

  1. The proximal femoral nail was made from titanium, its proximal part is narrow inside and wide outside structure. It looks like a trapezoidal in cross-section. This device was matched with the anatomy of proximal femur and its mechanical reliability.

  2. The tip of compression screw was designed thread. It can come through the intramedullary nail, produce slide and sustained pressure.

  3. The femoral support screw was made in cylindrical, had a blunt rounded tip. The tip of the femoral support screw was tabling with the groove of compression screw. This design can support interior mechanical stability. At the same time, the support screw from the femoral head and neck compression screw can slide fine-tuning, so it has a direct offset against varus and femoral neck rotating shift to prevent secondary loss of fracture reduction. The screw in the femoral head also can prevent cutting occurs.

  4. This device can be used in minimally invasive approach of percutaneous and implanted in body. Reduce reduction time, fracture interference and help the natural healing of fractures.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Treatment of Intertrochanteric Fracture With New Type of Intramedullary Nail
Study Start Date :
Sep 1, 2011
Anticipated Primary Completion Date :
Jul 1, 2015
Anticipated Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stable intertrochanteric fracture

The type of intertrochanteric fracture was below A2.1 (with A2.1) according to the AO/ATO classification.

Device: new type of intramedullary nail
This is a new fixation treat for intertrochanteric fracture.
Other Names:
  • WEIGAO ORTHOPAEDIC DEVICE CO.LTD.
  • ZL201020121021.6
  • Device: The intramedullary nail of PFNA
    It was used very common in treat with intertrochanteric fracture.
    Other Names:
  • AO Foundation
  • PFNA(proximal femoral nail antirotation)
  • Experimental: Unstable intertrochanteric fracture

    The type of intertrochanteric fracture was above A2.1 (without A2.1) according to the AO/ATO classification.

    Device: new type of intramedullary nail
    This is a new fixation treat for intertrochanteric fracture.
    Other Names:
  • WEIGAO ORTHOPAEDIC DEVICE CO.LTD.
  • ZL201020121021.6
  • Device: The intramedullary nail of PFNA
    It was used very common in treat with intertrochanteric fracture.
    Other Names:
  • AO Foundation
  • PFNA(proximal femoral nail antirotation)
  • Outcome Measures

    Primary Outcome Measures

    1. Bone healing condition [Six months]

      Bone healing condition was checked by radiological examination.

    Secondary Outcome Measures

    1. Rates of revision Rates of revision surgery [one year]

    2. Patient quality of life [one year]

      SF-36, ADL, Patient quality of life (SF-36, ADL, FIM)

    3. Complications [one year]

      mortality, nonunion, implant breakage/failure, infection, DVT

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adult men or women aged 18 years and older (with no upper age limit).

    • Fracture of the intertrochanteric fracture confirmed with either anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI).

    • Operative treatment of fractures within 14 days of presenting to the emergency room.

    • Patient was ambulatory prior to fracture, though they may have used an aid such as a cane or a walker.

    • Anticipated medical optimalization for operative fixation of the hip.

    • Provision of informed consent by patient or legal guardian.

    • No other major trauma.

    Exclusion Criteria:
    • Patients not suitable for internal fixation (i.e., severe osteoarthritis, rheumatoid arthritis, or pathologic fracture).

    • Associated major injuries of the lower extremity (i.e., ipsilateral or contralateral fractures of the foot, ankle, tibia, fibula, knee, or femur; dislocations of the ankle, knee, or hip; or femoral head defects or fracture).

    • Retained hardware around the affected hip.

    • Infection around the hip (i.e., soft tissue or bone).

    • Patients with disorders of bone metabolism except osteoporosis (i.e., Paget's disease, renal osteodystrophy, osteomalacia).

    • Moderate or severe cognitively impaired patients (i.e., Six Item Screener with 3 or more errors).

    • Patients with Parkinson's disease (or dementia) severe enough to increase the likelihood of falling or severe enough to compromise rehabilitation.

    • Likely problems, in the judgment of the investigators, with maintaining follow-up. We will, for example, exclude patients with no fixed address, those who report a plan to move out of town in the next year, or intellectually challenged patients without adequate family support

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Orthopedics department; The General Hospital of the People's Liberation Army Beijing Beijing China 100853

    Sponsors and Collaborators

    • Peifu Tang

    Investigators

    • Study Chair: Tang Peifu, Chinese PLA General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Peifu Tang, Chief, Professor, Chinese PLA General Hospital
    ClinicalTrials.gov Identifier:
    NCT01437176
    Other Study ID Numbers:
    • PLAGH OD 12
    First Posted:
    Sep 20, 2011
    Last Update Posted:
    Feb 6, 2015
    Last Verified:
    Feb 1, 2015
    Keywords provided by Peifu Tang, Chief, Professor, Chinese PLA General Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 6, 2015